Amneal Pharmaceuticals recalled 7,228 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall occurred due to the presence of a micro-organism in the packaging material. No micro-organisms were found on the tablets themselves.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 25 mg, sold in 100-count bottles. The affected lot numbers include AM240617 and AM240618, with an expiration date of April 30, 2027. The product was distributed nationwide in the USA.
The recall stems from the detection of a micro-organism in a specific lot of auxiliary polyester coil used in product packaging. This poses a potential contamination risk to consumers, although no micro-organisms were found on any of the tablets.
There are no reported incidents of illness or injury associated with the recalled tablets. The recall is classified as Class II due to the potential risk.
Consumers should stop using the recalled tablets immediately. Contact your healthcare provider or Amneal Pharmaceuticals, LLC for further guidance and information on how to dispose of the product.
For questions, call Amneal Pharmaceuticals at 1-XXX-XXXX. More information is available on the FDA's website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.